Abstract | BACKGROUND: METHODS: Forty-two patients with triglyceride concentrations between 5.65 and 22.60 mmol/l (500 and 2000 mg/dl) were studied in a prospective, double-blind, placebo-controlled trial of Omacor (4 g/day for 4 months). RESULTS: CONCLUSIONS:
|
Authors | W S Harris, H N Ginsberg, N Arunakul, N S Shachter, S L Windsor, M Adams, L Berglund, K Osmundsen |
Journal | Journal of cardiovascular risk
(J Cardiovasc Risk)
1997 Oct-Dec
Vol. 4
Issue 5-6
Pg. 385-91
ISSN: 1350-6277 [Print] England |
PMID | 9865671
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Fatty Acids, Omega-3
- Triglycerides
- Cholesterol
|
Topics |
- Cholesterol
(blood)
- Double-Blind Method
- Fatty Acids, Omega-3
(therapeutic use)
- Female
- Humans
- Hypertriglyceridemia
(blood, complications, drug therapy)
- Male
- Middle Aged
- Prospective Studies
- Triglycerides
(blood)
|